Guillaume Leurent
Latest contributions
PCR Tricuspid Focus Group - Referral Meeting à Rennes
23 Jun 2025
Rejoignez vos pairs pour ce referral meeting les 6 et 7 septembre 2024 à Rennes, en France !
Complication management during mitral TEER procedures
21 May 2025 – From EuroPCR 2025
Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.
RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation
25 Nov 2024 – From PCR London Valves 2024
Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...
Featured research - Mitral valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore the cutting edge of mitral valve research in this two-part featured research session. Dive into a diverse array of abstracts selected from the upcoming PCR London Valves 2024 conference, covering topics such as optimizing neo-left ventricular outflow tract area, addressing anatomical challenges in TMVR, the...
Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly
16 May 2024 – From EuroPCR 2024
Discover how to select suitable patients for TEER of primary mitral regurgitation, tackle anatomical challenges, understand the technique's limits, and gain insights into managing complexities and identifying cases where TEER may not be ideal.
Controversies in atrioventricular valves - The Heart Team ring, Vol II
19 Nov 2023 – From PCR London Valves 2023
This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.
